期刊文献+

血管支架置入辅助弹簧圈栓塞术后的颅内动脉瘤患者氯吡格雷抵抗影响因素分析 被引量:16

下载PDF
导出
摘要 目的探讨颅内动脉瘤患者颅内血管支架置入辅助弹簧圈栓塞术后氯吡格雷抵抗(CR)的影响因素。方法收集132例颅内动脉瘤患者的临床资料。本组患者均采用颅内血管支架置入辅助弹簧圈栓塞治疗,术后服用阿司匹林和氯吡格雷双联抗血小板,术后第5天进行血栓弹力图凝血分析仪检测二磷酸腺苷(ADP)诱导的血小板聚集抑制率,ADP诱导的血小板聚集抑制率<30%为CR。患者按是否存在术后CR分为CR组和对照组,比较两组基础临床资料(年龄、性别、吸烟史、高脂血症史)及临床生化检查结果(血小板计数、糖化血红蛋白、空腹血糖、甘油三酯、总胆固醇)。P<0.05者行多因素分析确定颅内动脉瘤患者颅内血管支架置入辅助弹簧圈栓塞术后氯吡格雷抵抗(CR)的独立危险因素。结果术后第5天CR 36例(CR发生率27.3%,CR组),氯吡格雷敏感96例(对照组)。两组患者女性构成比、血小板计数和糖化血红蛋白水平相比,P均<0.05;吸烟、高血压、高脂血症构成比及空腹血糖、甘油三酯、总胆固醇水平相比,P均>0.05。Logistic回归分析结果显示,女性(OR为1.60,95%CI为1.05~3.20)、高糖化血红蛋白(OR为2.68,95%CI为1.10~5.46)、血小板计数增高(OR为2.13,95%CI为1.03~4.15)均是颅内动脉瘤患者颅内血管支架置入辅助弹簧圈栓塞术后CR的独立危险因素,P均<0.05。结论女性、高糖化血红蛋白、血小板计数增高是颅内动脉瘤患者颅内血管支架置入辅助弹簧圈栓塞术后CR的危险因素。
机构地区 滨州市人民医院
出处 《山东医药》 CAS 北大核心 2017年第11期49-51,共3页 Shandong Medical Journal
  • 相关文献

参考文献3

二级参考文献28

  • 1潘毅.心气虚证计量诊断再探[J].广州中医学院学报,1995,12(1):10-13. 被引量:20
  • 2de la Torre-Hernandez JM, Alfonso F, Hernaindez F, et al. Drug- eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA. J Am Coil Cardiol, 2008, 51 : 986-990.
  • 3Nguyen TA, Diodati JG, Pharand C. Resistance to clopidogrel: a review of the evidence. J Am Coll Cardiol, 2005,45:1157-1164.
  • 4Marcucci R, Gori AM, Paniccia R, et al. Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stentiug are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12- month follow-up. Circulation, 2009, 119:237-242.
  • 5Price MJ, Endemann S, Gollapudi RR, et al. Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation. Eur Heart J, 2008, 29:992-1000.
  • 6von Beckerath N, Pogatsa-Murray G, Wieczorek A, et al. Correlation of a new point-of-care test with conventional optical aggregometry for the assessment of clopidogrel responsiveness. Thromb Haemost, 2006, 95:910 -911.
  • 7Suh JW, Lee SP, Park KW, et al. Muhicenter randomized trial evaluating the efficacy of cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease: results of the CILON-T (influence of eilostazol- based triple antiplatelet therapy on ischemic complication 'after drug-eluting stent implantation) trial. J Am Coil Cardiol, 2011, 57:280-289.
  • 8Price M J, Berger PB, Teirstein PS, et al. Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRA VITAS randomized trial. .lAMA, 2011, 305 : 1097-1105.
  • 9Berger JS, Bhatt DL, Cannon CP, et al. The relative efficacy and safety of elopidogrel in women and men a sex-specific collaborative meta-analysis. J Am Coll Cardiol, 2009, 54 : 1935-1945.
  • 10Dorsch MP, Lee JS, Lynch DR, et al. Aspirin resistance in patients with stable coronary artery disease with and without a history of myocardial infarction. Ann Pharmacother, 2007, 41: 737-741.

共引文献39

同被引文献149

引证文献16

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部